ES2529315T5 - Polímeros recombinantes no estructurados y usos de los mismos - Google Patents

Polímeros recombinantes no estructurados y usos de los mismos Download PDF

Info

Publication number
ES2529315T5
ES2529315T5 ES11172812T ES11172812T ES2529315T5 ES 2529315 T5 ES2529315 T5 ES 2529315T5 ES 11172812 T ES11172812 T ES 11172812T ES 11172812 T ES11172812 T ES 11172812T ES 2529315 T5 ES2529315 T5 ES 2529315T5
Authority
ES
Spain
Prior art keywords
protein
urp
sequences
binding
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11172812T
Other languages
English (en)
Spanish (es)
Other versions
ES2529315T3 (es
ES2529315T9 (es
Inventor
Volker Schellenberger
Willem P Stemmer
Chia-Wei Wang
Michael D Scholle
Mikhail Popkov
Nathaniel C Gordon
Andreas Crameri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amunix Pharmaceuticals Inc
Original Assignee
Amunix Operating Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48527357&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2529315(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/528,927 external-priority patent/US20070191272A1/en
Application filed by Amunix Operating Inc filed Critical Amunix Operating Inc
Publication of ES2529315T3 publication Critical patent/ES2529315T3/es
Publication of ES2529315T9 publication Critical patent/ES2529315T9/es
Application granted granted Critical
Publication of ES2529315T5 publication Critical patent/ES2529315T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
ES11172812T 2006-03-06 2007-03-06 Polímeros recombinantes no estructurados y usos de los mismos Active ES2529315T5 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US74341006P 2006-03-06 2006-03-06
US743410P 2006-03-06
US74362206P 2006-03-21 2006-03-21
US743622P 2006-03-21
US11/528,927 US20070191272A1 (en) 2005-09-27 2006-09-27 Proteinaceous pharmaceuticals and uses thereof
US528950 2006-09-27
US528927 2006-09-27
US11/528,950 US20070212703A1 (en) 2005-09-27 2006-09-27 Proteinaceous pharmaceuticals and uses thereof

Publications (3)

Publication Number Publication Date
ES2529315T3 ES2529315T3 (es) 2015-02-19
ES2529315T9 ES2529315T9 (es) 2015-05-29
ES2529315T5 true ES2529315T5 (es) 2024-02-23

Family

ID=48527357

Family Applications (2)

Application Number Title Priority Date Filing Date
ES11172812T Active ES2529315T5 (es) 2006-03-06 2007-03-06 Polímeros recombinantes no estructurados y usos de los mismos
ES07752636T Active ES2417153T5 (es) 2006-03-06 2007-03-06 Polímeros recombinantes no estructurados y usos de los mismos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES07752636T Active ES2417153T5 (es) 2006-03-06 2007-03-06 Polímeros recombinantes no estructurados y usos de los mismos

Country Status (7)

Country Link
EP (1) EP2402754B2 (https=)
JP (4) JP2013081481A (https=)
CN (1) CN103360471B (https=)
DK (1) DK1996220T4 (https=)
ES (2) ES2529315T5 (https=)
FI (2) FI1996220T4 (https=)
HK (1) HK1203624A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2573103B1 (en) 2010-01-29 2017-07-05 Archer-Daniels-Midland Company Peptide domains that bind small molecules of industrial significance
JP6246128B2 (ja) * 2012-09-14 2017-12-13 公益財団法人がん研究会 ＥｐＣＡＭに結合するペプチド
EP2948471A4 (en) * 2013-01-24 2016-08-10 Mayo Foundation METHOD AND MATERIALS FOR DETECTING POSITIVE FRONTOTEMPORAL PAPER DEGENERATION BY C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION OR AMYOTROPHATE LATERAL SCLEROSIS BY C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION
CN105985444B (zh) * 2015-02-05 2024-02-13 博生吉安科细胞技术有限公司 一种嵌合抗原受体、以及快速构建嵌合抗原受体的方法及应用
WO2016146174A1 (en) * 2015-03-17 2016-09-22 Biontech Ag Compositions and methods for diagnosis and treatment of cancer
IT201700122135A1 (it) * 2017-10-26 2019-04-26 Jointherapeutics S R L Acido ialuronico funzionalizzato o suo derivato nel trattamento di stati infiammatori
CN108931513B (zh) * 2018-08-28 2021-11-19 河南省医药科学研究院 体外检测MUSK-Ab和LRP4-Ab的方法及试剂盒
US11492384B2 (en) * 2018-09-17 2022-11-08 Gi Innovation, Inc. Fusion protein comprising IL-2 protein and CD80 protein, and use thereof
CN120608002A (zh) * 2018-11-27 2025-09-09 科纳科学控股有限公司 用于生物合成大麻素的双向多酶支架
CN111948404B (zh) * 2020-08-03 2023-04-07 融智生物科技（青岛）有限公司 用于筛查地中海贫血的特征蛋白标记组合物、质谱模型及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225449B1 (en) † 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
US20050287153A1 (en) * 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US20030049689A1 (en) * 2000-12-14 2003-03-13 Cynthia Edwards Multifunctional polypeptides
US20020169125A1 (en) † 2001-03-21 2002-11-14 Cell Therapeutics, Inc. Recombinant production of polyanionic polymers and uses thereof
US7081446B2 (en) † 2002-01-31 2006-07-25 The Trustees Of Columbia University In The City Of New York Long-acting follicle stimulating hormone analogues and uses thereof
EP1633382A4 (en) † 2003-05-14 2009-08-05 Dow Corning REPEAT SEQUENCE PROTEIN-POLYMER-ACTIVE CONJUGATE, METHOD AND USES
BRPI0606934A2 (pt) † 2005-01-25 2017-07-11 Cell Therapeutics Inc Conjugado de proteína biologicamente ativa, composição, molécula de dna quimérica, vetor, célula, e, métodos para preparar conjugado de proteína biologicamente ativa, e para determinar se um dado conjugado de proteína exibe uma meia-vida de plasma modificada comparada com a meia-vida intrínseca do polipeptídeo biologicamente ativo não conjungado
US7855279B2 (en) † 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
WO2007073486A2 (en) † 2005-12-20 2007-06-28 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
WO2008049711A1 (en) † 2006-10-27 2008-05-02 Novo Nordisk A/S Peptide extended insulins

Also Published As

Publication number Publication date
EP2402754B9 (en) 2015-03-11
JP2013081481A (ja) 2013-05-09
JP2014198050A (ja) 2014-10-23
JP6175030B2 (ja) 2017-08-02
JP2016185990A (ja) 2016-10-27
EP2402754A3 (en) 2012-04-18
JP2015006202A (ja) 2015-01-15
DK1996220T3 (da) 2013-07-08
DK1996220T4 (da) 2023-11-13
ES2417153T3 (es) 2013-08-06
FI1996220T4 (fi) 2023-11-09
ES2529315T3 (es) 2015-02-19
CN103360471A (zh) 2013-10-23
EP2402754B2 (en) 2023-07-26
ES2417153T5 (es) 2024-04-04
EP2402754B1 (en) 2014-11-19
CN103360471B (zh) 2016-04-27
HK1203624A1 (en) 2015-10-30
ES2529315T9 (es) 2015-05-29
FI2402754T4 (fi) 2023-10-06
EP2402754A2 (en) 2012-01-04

Similar Documents

Publication Publication Date Title
US9938331B2 (en) Biologically active proteins having increased in vivo and/or in vitro stability
US7846445B2 (en) Methods for production of unstructured recombinant polymers and uses thereof
EP1996220B2 (en) Unstructured recombinant polymers and uses thereof
US20090099031A1 (en) Genetic package and uses thereof
CN101616685B (zh) 非结构化重组聚合物和其应用
ES2529315T5 (es) Polímeros recombinantes no estructurados y usos de los mismos
CA2644548A1 (en) Genetic packages and uses thereof
HK1163245B (en) Unstructured recombinant polymers and uses thereof
HK1163245A1 (en) Unstructured recombinant polymers and uses thereof